| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 12/13/2001 | CA2410458A1 Methods and compositions for inhibiting immunoglobulin-mediated__reperfusion injury |
| 12/13/2001 | CA2409392A1 Intracellular signaling proteins |
| 12/13/2001 | CA2409342A1 Extracellular messengers |
| 12/13/2001 | CA2408748A1 Nuclear hormone receptor |
| 12/12/2001 | EP1162270A2 Phagemids coexpressing a surface receptor and a surface heterologous protein |
| 12/12/2001 | EP1162269A1 Novel polypeptide |
| 12/12/2001 | EP1162264A2 Chimeric hormone receptor |
| 12/12/2001 | EP1161954A1 Treatment of T cell mediated autoimmune disorders |
| 12/12/2001 | EP1161549A2 Retrovirus producing cells utilizing a high multiplicity of transduction |
| 12/12/2001 | EP1161548A2 Recombinant protein production in a human cell using sequences encoding adenovirus e1 protein |
| 12/12/2001 | EP1161530A1 Protein for blocking platelet adhesion |
| 12/12/2001 | EP1161522A1 Method of isolating cd8+ cells, and related hybridoma cells, antibodies and polypeptides |
| 12/12/2001 | EP1161455A1 A novel chimeric protein for prevention and treatment of hiv infection |
| 12/12/2001 | EP1161454A2 Peptides with anti-angiogenic activity |
| 12/12/2001 | EP1161450A1 Bone stimulating factor |
| 12/12/2001 | EP1161448A1 49 human secreted proteins |
| 12/12/2001 | EP1161447A1 50 human secreted proteins |
| 12/12/2001 | EP1161446A1 50 human secreted proteins |
| 12/12/2001 | EP1161442A2 Exocytosis pathway proteins and methods of use |
| 12/12/2001 | EP1161266A1 Matriptase, a serine protease and its applications |
| 12/12/2001 | EP1161261A1 Apoptosis inducing molecule ii and methods of use |
| 12/12/2001 | EP1161250A1 Immunostimulant bacterial membrane fractions in cancer treatment |
| 12/12/2001 | EP1017709A4 G-protein coupled glycoprotein hormone receptor aomf05 |
| 12/12/2001 | EP0809656B1 MONOCLONAL ANTIBODY SPECIFIC FOR beta-A4 PEPTIDE |
| 12/12/2001 | EP0787144B1 Major outer membrane protein cd of moraxella |
| 12/12/2001 | EP0783586B1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
| 12/12/2001 | EP0651789B1 Method for preventing zoster and alleviating varicella related post-herpetic neuralgia |
| 12/12/2001 | EP0522159B1 Antibody to pituitary adenylate cyclase activating peptide-pacap, hybridoma and assay for pacap |
| 12/12/2001 | CN1326509A MOraxella catarrhalis ABSB034 polypeptides and uses thereof |
| 12/12/2001 | CN1326508A Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses |
| 12/12/2001 | CN1326467A Expression and export of angiostation and endostatin as immunofusins |
| 12/12/2001 | CN1326466A Method of producing functional immunoglubulin superfaminly protein |
| 12/12/2001 | CN1076052C Nucleic acid sequences, carrier containing them, medical compositions and usage for treatment |
| 12/11/2001 | US6329572 Plant promoter activated by fungal infection |
| 12/11/2001 | US6329568 Tospovirus resistance in plants |
| 12/11/2001 | US6329566 Methods for the detection, treatment, and prevention of neurodegeneration |
| 12/11/2001 | US6329518 Nucleic acid from crepis plant coding for enzyme that catalyzes epoxygenation of carbon double bond at delta-12 position of fatty acid; efficient production of coatings, glues, plastics, surfactants and lubricants |
| 12/11/2001 | US6329517 Dermatomyositis-specific auto-antigen |
| 12/11/2001 | US6329507 Dimer and multimer forms of single chain polypeptides |
| 12/11/2001 | US6329503 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 12/11/2001 | US6329417 Hepatitis C inhibitor tri-pepitides |
| 12/11/2001 | US6329379 Oligopeptides for inhibiting hepatitis |
| 12/11/2001 | US6329341 Method of treating septic shock |
| 12/11/2001 | US6329340 Human Defensin DEF-X |
| 12/11/2001 | US6329202 Antibodies directed against binding associated epitopes |
| 12/11/2001 | US6329198 Production and use of human nm23 protein and antibodies therefor |
| 12/11/2001 | US6329197 DNA encoding galanin GALR3 receptors and uses thereof |
| 12/11/2001 | US6329190 Targetting adenovirus with use of constrained peptide motifs |
| 12/11/2001 | US6329176 Culturing mammals cells containing a nucleic acid sequence that codes a saccharomyces endoprotease, in a serum free medium and isolating the protein from the medium |
| 12/11/2001 | US6329173 Method of intracellular binding target molecules |
| 12/11/2001 | US6329159 An antibody or antigen binding fragment which binds mammalian chemokine receptor and inhibits the binding of ligand to the receptor; therapy and diagnosis of inflammatory disease associated with mucosal tissues |
| 12/11/2001 | US6329141 Genetically engineered dna that when transformed in phaffia rhodozyme is highly expressed in the glycolytic pathway coding for glyceraldehye-3-phosphate dehydrogenase or a ribosomal protein encoding gene |
| 12/11/2001 | US6328973 Method of raising neutralizing antibodies against HIV |
| 12/11/2001 | US6328970 Rapamycin position 27 conjugates |
| 12/11/2001 | US6328968 Organ transplant |
| 12/11/2001 | US6328964 Method to treat multiple sclerosis with GP39-specific antibodies |
| 12/11/2001 | US6328963 For purifying or assaying human mp52 produced b genetic engineering techniques |
| 12/11/2001 | US6328962 Conjugate molecules are produced by genetic modification of genes encoding light and heavy chains of the surface structure specific antibody and expression in mammal cells to produce the conjugated antibody; enhanced immune response |
| 12/11/2001 | US6328957 Heat shock proteins and the treatment of tumors |
| 12/11/2001 | CA2329482C Recombinant antibodies specific for tnf-.alpha. |
| 12/11/2001 | CA2162132C Hepatitis b virus mutants, reagents and methods for detection |
| 12/11/2001 | CA2136429C Combined vaccines comprising hepatitis b surface antigen and other antigens |
| 12/11/2001 | CA2136094C Methods and compositions for increasing the sensitivity of a cell to a dna damaging agent |
| 12/11/2001 | CA2117953C Human stromal derived factor 1 alpha and 1 beta and dnas encoding the same |
| 12/11/2001 | CA2065874C Hybridoma ct43 producing a monoclonal antibody to a mucin epitope of colorectal cancer |
| 12/11/2001 | CA2050477C T cell growth factor |
| 12/11/2001 | CA2022487C Optimized fermentation processes for the preparation of foreign proteins in e.coli |
| 12/06/2001 | WO2001092543A2 Improved methods of transfection |
| 12/06/2001 | WO2001092542A2 Integrin-targeting vectors having enhanced transfection activity |
| 12/06/2001 | WO2001092533A1 Anti-listeria bacteriocin |
| 12/06/2001 | WO2001092532A1 Cloning and sequencing of dac g5 allergen of dactylis glomerata pollen, preparation and use thereof |
| 12/06/2001 | WO2001092530A1 Nucleic acid molecule comprising a nucleic acid sequence coding for an sdf-1 gamma chemokine, a neuropeptide precursor or at least one neuropeptide |
| 12/06/2001 | WO2001092529A1 A variable region of the monoclonal antibody against the hbv s-surface antigen and a gene encoding the same |
| 12/06/2001 | WO2001092527A2 Regulators of apoptosis |
| 12/06/2001 | WO2001092526A1 Human kcnq5 potassium channel, methods and compositions thereof |
| 12/06/2001 | WO2001092507A1 Shedding fragments of cd44, utilization thereof and inhibition of the shedding |
| 12/06/2001 | WO2001092485A1 DNAs ENCODING MAMMALIAN HISTAMINE RECEPTOR OF THE H4 SUBTYPE |
| 12/06/2001 | WO2001092469A2 Phosphorylated polypeptides and uses related thereto |
| 12/06/2001 | WO2001092337A2 Soluble ctla4 mutant molecules and uses thereof |
| 12/06/2001 | WO2001092321A2 Proteins involved in cytoadhesion of plasmodium falciparum ring-stage-infected erythrocytes |
| 12/06/2001 | WO2001092308A2 Cystine-knot polypeptides: cloaked-2 molecules and uses thereof |
| 12/06/2001 | WO2001092304A2 Transporters and ion channels |
| 12/06/2001 | WO2001091793A1 Anti-rank ligand monoclonal antibodies useful in treatment of rank ligand mediated disorders |
| 12/06/2001 | WO2001091787A1 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy |
| 12/06/2001 | WO2001091698A2 Genetically-engineered mhc molecules |
| 12/06/2001 | WO2001068805A8 Human olfactory receptors and genes encoding same |
| 12/06/2001 | WO2001064922A3 Heterologous expression of neisserial proteins |
| 12/06/2001 | WO2001057216A3 Method for the production of a protein |
| 12/06/2001 | WO2001046224A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
| 12/06/2001 | WO2001034647A3 Animal collagens and gelatins |
| 12/06/2001 | WO2001034646A3 Recombinant gelatins |
| 12/06/2001 | WO2001032864A3 Gpcr-kd5 polypeptides and dna sequences thereof |
| 12/06/2001 | WO2001027630A3 Methods to identify compounds that modulate neuronal activity |
| 12/06/2001 | WO2001027150A3 Anthozoa derived chromo/fluoroproteins and methods for using the same |
| 12/06/2001 | WO2001014416A3 Synthetic papillomavirus genes optimized for expression in human cells |
| 12/06/2001 | WO2001012775A8 25 human secreted proteins |
| 12/06/2001 | WO2001012662A3 Membrane associated proteins |
| 12/06/2001 | WO2000077233A3 Complement-resistant non-mammalian dna viruses and uses thereof |
| 12/06/2001 | WO2000061750A3 TYROSINE KINASE SUBSTRATE (Tks) PROTEINS |
| 12/06/2001 | WO2000050443A9 Secreted proteins and uses thereof |